| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911478 | Lung Cancer | 2012 | 7 Pages |
Abstract
The relatively high expression of FATS mRNA provides a new biomarker for a good outcome in patients receiving cisplatin-based chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yin Tian, Jun Zhang, Shuangshuang Yan, Li Qiu, Zheng Li,